Ehud Schwammenthal

Magenta Medical Ltd. develops medical devices for the treatment of acute and congestive heart failure. It offers a temporary venous catheter-based therapy for hospital-admitted patients. The firm?s novel therapeutic principle is aimed at addressing renal venous congestion and its deleterious effects on renal and cardiac function that is a pathophysiological core element of acute heart failure. The company was founded by Ehud Schwammenthal and Yosi Tuval in October 2012 and is headquartered in Kadima, Israel.

AISAP Ltd. is a company based in Ramat Gan, Israel that was founded by Ehud Raanani, Adiel Am-Shalom, Robert Klempfner, and Ehud Schwammenthal. The Israeli company specializes in providing AI-powered ultrasound diagnosis through their main product, AISAP POCAD™. The platform is designed to empower clinicians and connect care teams to provide immediate, efficient, and fast treatment, right at the patient's bedside. The company's goal is to transform the daily interface between physician and patient at the point of care and enable advanced medicine to be accessible to more people in need, no matter how remote - in the hospital, in the clinic, and in the home. Adiel Am-Shalom has been the CEO since incorporation.